- Home
- WES vs HOLX Comparison
WES vs HOLX Comparison
Compare WES & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WES | HOLX |
|---|---|---|
| Founded | 2007 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Medical Electronics |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3B | 16.9B |
| IPO Year | 2012 | 1995 |
Fundamental Metrics
Financial Performance| Metric | WES | HOLX |
|---|---|---|
| Price | $46.22 | $76.02 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 7 | 13 |
| Target Price | $41.71 | ★ $77.89 |
| AVG Volume (30 Days) | 1.4M | ★ 95.4M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 8.81% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | $3,843,403,000.00 | ★ $4,100,500,000.00 |
| Revenue This Year | $6.42 | $4.74 |
| Revenue Next Year | $6.99 | $5.03 |
| P/E Ratio | ★ $14.73 | $96.23 |
| Revenue Growth | ★ 6.61 | 1.74 |
| 52 Week Low | $36.90 | $53.62 |
| 52 Week High | $47.45 | $76.07 |
Technical Indicators
Market Signals| Indicator | WES | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 66.79 | 69.09 |
| Support Level | $40.00 | $75.10 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.23 | 0.19 |
| MACD | 0.39 | 0.03 |
| Stochastic Oscillator | 76.21 | 95.19 |
Price Performance
Historical ComparisonAbout WES Western Midstream Partners LP
Western Midstream Partners LP is a USA-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma) and Texas.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.